These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 35801728)

  • 1. The role of toll-like receptors (TLRs) in pan-cancer.
    Huang R; Sun Z; Xian S; Song D; Chang Z; Yan P; Zhang J; Yin H; Zheng Z; Hu P; Li Z; Huang D; Liu Y; Jiang C; Li M; Li S; Meng T; Yang D; Huang Z
    Ann Med; 2022 Dec; 54(1):1918-1937. PubMed ID: 35801728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-Like Receptors (TLRs) in the Tumor Microenvironment (TME): A Dragon-Like Weapon in a Non-fantasy Game of Thrones.
    Angrini M; Varthaman A; Cremer I
    Adv Exp Med Biol; 2020; 1263():145-173. PubMed ID: 32588327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive Bioinformatics Analysis of Toll-Like Receptors (TLRs) in Pan-Cancer.
    Ping W; Hong S; Xun Y; Li C
    Biomed Res Int; 2022; 2022():4436646. PubMed ID: 35937402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Important aspects of Toll-like receptors, ligands and their signaling pathways.
    Chang ZL
    Inflamm Res; 2010 Oct; 59(10):791-808. PubMed ID: 20593217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer.
    Matboli M; Hossam N; Farag D; Hassan M; Shehata H; Aboelhussein M; Ismail N; Eissa S
    BMC Cancer; 2024 Jul; 24(1):824. PubMed ID: 38987740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toll-like receptor signaling in colorectal cancer: carcinogenesis to cancer therapy.
    Li TT; Ogino S; Qian ZR
    World J Gastroenterol; 2014 Dec; 20(47):17699-708. PubMed ID: 25548469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptors (TLRs): An old family of immune receptors with a new face in cancer pathogenesis.
    Mokhtari Y; Pourbagheri-Sigaroodi A; Zafari P; Bagheri N; Ghaffari SH; Bashash D
    J Cell Mol Med; 2021 Jan; 25(2):639-651. PubMed ID: 33336901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of toll-like receptors in cancer: a double-edged sword for defense and offense.
    Basith S; Manavalan B; Yoo TH; Kim SG; Choi S
    Arch Pharm Res; 2012 Aug; 35(8):1297-316. PubMed ID: 22941474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword.
    Dajon M; Iribarren K; Cremer I
    Immunobiology; 2017 Jan; 222(1):89-100. PubMed ID: 27349597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profile of Toll‑like receptors in human breast cancer.
    Shi S; Xu C; Fang X; Zhang Y; Li H; Wen W; Yang G
    Mol Med Rep; 2020 Feb; 21(2):786-794. PubMed ID: 31789409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptors TLR-2, TLR-4, TLR-7, and TLR-9 in tumor tissue and serum of the patients with esophageal squamous cell carcinoma and gastro-esophageal junction cancer.
    Diakowska D; Nienartowicz M; Grabowski K; Rosińczuk J; Krzystek-Korpacka M
    Adv Clin Exp Med; 2019 Apr; 28(4):515-522. PubMed ID: 29968427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptor-targeted particles: A paradigm to manipulate the tumor microenvironment for cancer immunotherapy.
    Tran TH; Tran TTP; Truong DH; Nguyen HT; Pham TT; Yong CS; Kim JO
    Acta Biomater; 2019 Aug; 94():82-96. PubMed ID: 31129358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptors: The role in bladder cancer development, progression and immunotherapy.
    Ohadian Moghadam S; Nowroozi MR
    Scand J Immunol; 2019 Dec; 90(6):e12818. PubMed ID: 31448424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fc Fragment of IgE Receptor Ig (FCER1G) acts as a key gene involved in cancer immune infiltration and tumour microenvironment.
    Yang R; Chen Z; Liang L; Ao S; Zhang J; Chang Z; Wang Z; Zhou Y; Duan X; Deng T
    Immunology; 2023 Feb; 168(2):302-319. PubMed ID: 36054819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathways: toll-like receptors in the tumor microenvironment--poor prognosis or new therapeutic opportunity.
    Ridnour LA; Cheng RY; Switzer CH; Heinecke JL; Ambs S; Glynn S; Young HA; Trinchieri G; Wink DA
    Clin Cancer Res; 2013 Mar; 19(6):1340-6. PubMed ID: 23271799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.
    Wu G; He M; Yin X; Wang W; Zhou J; Ren K; Chen X; Xue Q
    Front Immunol; 2022; 13():837665. PubMed ID: 35493463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic understanding and therapeutic approaches to target toll-like receptors in cancerous microenvironment and metastasis.
    Khajeh Alizadeh Attar M; Anwar MA; Eskian M; Keshavarz-Fathi M; Choi S; Rezaei N
    Med Res Rev; 2018 Sep; 38(5):1469-1484. PubMed ID: 29283184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A specific Toll-like receptor profile on T lymphocytes and values of monocytes correlate with bacterial, fungal, and cytomegalovirus infections in the early period of allogeneic stem cell transplantation.
    Skert C; Fogli M; Garaffa E; Perucca S; Fiorentini S; Cancelli V; Turra A; Ribolla R; Filì C; Malagola M; Bergonzi C; Cattina F; Bernardi S; Caruso A; Di Palma A; Russo D
    Transpl Infect Dis; 2014 Oct; 16(5):697-712. PubMed ID: 25040166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of toll-like receptors (TLRs) and their therapeutic applications in endometrial cancer.
    Arabian S; Boostan A; Darzi S
    Clin Transl Oncol; 2023 Apr; 25(4):859-865. PubMed ID: 36374404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics and therapeutic implications of Toll-like receptor signaling pathway in melanoma.
    Guan H; Chen X; Liu J; Sun J; Guo H; Jiang Y; Zhang H; Zhang B; Lin J; Yuan Q
    Sci Rep; 2023 Sep; 13(1):13788. PubMed ID: 37666853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.